Author:
Bokemeyer C.,Kuczyk M. A.,K�hne H.,Einsele H.,Kynast B.,Schmoll H. -J.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference62 articles.
1. Amman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frei E, Schnipper LE (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319:593?598
2. Bajorin DF, Nichols CR, Schmoll HJ, Kantoff PW, Bokemeyer C, Demetri GD, Einhorn LH, Bosl GJ (1995) Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial. J Clin Oncol 13:79?86
3. Beyer J, Schwella N, Strohscheer I, Schwander I, Zingsem J, Serke S, Huhn D, Siegert W (1994) Randomized comparison of hematopoietic rescue with stem/progenitor cells from bone marrow or peripheral blood after high-dose chemotherapy in germ cell tumors. Bone Marrow Transplant 14 [Suppl 1]: 45
4. Birch R, Williams S, Cone A, Einhorn LH, Roark P, Turner S, Greco FA (1986) Prognostic factors for favourable outcome in disseminated germ cell tumours. J Clin Oncol 4:400?407
5. Blanke C, Loehrer PJ, Einhorn LH, Nichols C (1994) A phase-II study of VP-16 plus ifosfamide plus cisplatin plus vinblastine plus bleomycin (VIP/VB) with filgrastim for advanced stage testicular cancer. Proc Am Soc Clin Oncol 13:234
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献